Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
05/2007
05/22/2007CA2219692C S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
05/18/2007WO2007056550A2 Processes for preparation of maytansinol
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007056155A1 Heterocyclic compounds as tyrosine kinase modulators
05/18/2007WO2007056086A2 Rifamycin analogs and uses thereof
05/18/2007WO2007055418A1 Aza-substituted spiro derivative
05/18/2007WO2007054580A1 N-sulfamoyl-n’-benzopyranpiperidines as inhbitors of carbonic anhydrases
05/18/2007WO2007054517A1 Syntesis of tetrodotoxin , its analogues and intermediates thereof
05/18/2007WO2007054470A1 Use of rylene derivatives as photosensitizers in solar cells
05/18/2007WO2007054138A1 Substituted tetrahydroquinolines
05/18/2007WO2007029037A3 Class iia histone deacetylase (hdac) substrate
05/18/2007WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
05/18/2007WO2006109085A8 Hydroxybenzamide derivatives and their use as inhibitors of hsp90
05/18/2007WO2006028525A3 [3.2.0] heterocyclic compounds and methods of using the same
05/18/2007CA2669736A1 Heterocyclic compounds as tyrosine kinase modulators
05/18/2007CA2629864A1 N-sulfamoyl-n'-benzopyranpiperidines as inhbitors of carbonic anhydrases
05/18/2007CA2629018A1 Aza-substituted spiro derivative
05/18/2007CA2625867A1 Processes for preparation of maytansinol
05/18/2007CA2611889A1 Substituted tetrahydroquinolines
05/17/2007US20070112198 alkylating isoxazolo[5,4-c]pyridin-3-ol with benzyl bromide to form 6-benzyl-3-hydroxy-isoxazolo[5,4-c] pyridin-6-ium bromide, reducing intermediate with NaBH4 to form 6-benzyl-4,5,6,7-tetrahydro-isoxazolo[5,4-c]pyridin-3-ol
05/17/2007US20070112188 Reducing a C3-ester of maytansinol with an aluminum-based hydride reducing agent, quenching the reduction reaction, and subjecting the quenched mixture to a holding step to convert the C3 to C9 bridged acetal formed into maytansinol; the bridged intermediate is also claimed
05/17/2007US20070112015 Substituted dihydropyridines and methods of use
05/17/2007US20070111991 10,11-Dihydro-dibenzo[b,f]oxepine-10-carboxylic acid [(1S*,2S*,4R*)-4-butylcarbamoyl-2-hydroxy-1-(3-hydroxy-benzyl)-pentyl]-amide; treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation
05/17/2007US20070111985 HIV integrase inhibitors
05/17/2007US20070111984 HIV integrase inhibitors
05/17/2007US20070111950 Indole compounds useful for the treatment of cancer
05/16/2007EP1785427A1 Syntesis of tetrodotoxin, its analogues and intermediates thereof
05/16/2007EP1785415A1 Piperidine derivative or pharmaceutically acceptable salt thereof
05/16/2007EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
05/16/2007EP1784390A2 Substituted benzofused heterocycles
05/16/2007EP1697380B1 The method of manufacturing of 7-ethyl-10-hydroxycamptothecin
05/16/2007EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/16/2007EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/16/2007EP1115405B1 Use of tnf-alpha inhibitors for treating nerve root injury
05/16/2007CN1964979A Novel water-soluble prodrug
05/16/2007CN1964978A Furanopyrimidine compounds effective as potassium channel inhibitors
05/16/2007CN1964977A Annelated quinoline derivatives as pesticide
05/16/2007CN1964976A Extraction of alkaloids from opium
05/16/2007CN1964713A Co-administration of dopamine-receptor binding compounds
05/16/2007CN1962635A Indoles compound preparation method
05/16/2007CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
05/16/2007CN1315834C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/16/2007CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
05/15/2007US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/15/2007US7217730 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus
05/15/2007US7217709 Tetracyclic benzamide derivatives and methods of use thereof
05/15/2007CA2392973C Benzoimidazole derivatives useful as antiproliferative agents
05/15/2007CA2374767C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
05/15/2007CA2148612C 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as pesticides
05/10/2007WO2007053684A2 Neuroprotective agents
05/10/2007WO2007053650A2 Diazonamide a analog
05/10/2007WO2007023281A3 Biologically active compounds
05/10/2007WO2007022102A3 Pentacyclic kinase inhibitors
05/10/2007WO2007008539A3 Pyranopyridine compounds
05/10/2007US20070106077 Synthesis of substituted heterocyclic compounds
05/10/2007US20070105943 Novel antifungal agent containing heterocyclic compound
05/10/2007US20070105892 Amidino compounds as cysteine protease inhibitors
05/10/2007US20070105890 Novel condensed imidazole derivative
05/10/2007US20070105889 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for therapy of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea
05/10/2007US20070105888 Metabolically resistant 41-[13C]methoxyl rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (41-[13C]methoxyl CCI-779); study pharmacokinetics; Rapamycin 31-O-trimethyl silyl ether, 42-ester with 2,2,5-trimethyl[1,3-dioxane]-5-carboxylic acid; treat cancers
05/10/2007US20070105885 Novel crystalline polymorphic form of a camptothecin analogue
05/10/2007US20070105884 Opiate analogs selective for the delta-opioid receptor
05/10/2007US20070105849 Rifamycin analogs and uses thereof
05/10/2007US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases
05/10/2007US20070105837 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2][2]-benzazepine, method for the production thereof and use thereof in the production of medicaments
05/10/2007US20070105721 Vinylogous 4-Hpyrones and their use in promoting plant growth
05/10/2007US20070102695 Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon
05/09/2007EP1781664A1 Inhibitors of vegf receptor and hgf receptor signaling
05/09/2007EP1781623A1 Compounds and compositions useful as cathepsin s inhibitors
05/09/2007EP1781619A1 Sigma receptor inhibitors
05/09/2007EP1781296A2 Quinazoline derivatives and their use in the treatment of thrombocythemia
05/09/2007EP1781288A2 Modulators of muscarinic receptors
05/09/2007CN1960982A Method for producing 1,3-dioxolan-4,6-dione compound
05/09/2007CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd
05/09/2007CN1314393C Method for treating hair-dropping using thyromimetic compound
05/08/2007US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics
05/08/2007US7214797 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
05/08/2007US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases
05/08/2007US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
05/08/2007US7214703 Compounds for modulators of chemokine activity
05/08/2007US7214681 Tri(cyclo) substituted amide compounds
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/08/2007CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines
05/03/2007WO2007051062A2 Substituted dihydropyridines and methods of use
05/03/2007WO2007050892A2 Camptothecin derivatives and improved synthetic methods
05/03/2007WO2007050124A1 Fused piperidine derivatives and their uses as therapeutic agents
05/03/2007WO2007027855A3 Raf inhibitor compounds and methods of use thereof
05/03/2007WO2007016028A3 Synthesis and crystalline forms of npy5 antagonist
05/03/2007WO2007009120A3 Heterotetracyclic compounds as tpo mimetics
05/03/2007WO2006105056A3 Insecticidal 2,4-diaminoquinazolines and related derivatives
05/03/2007US20070100135 heating under microwave irradiation (3-hydroxymethylene-4-carboxylic acid ester-2-one)pyrroline derivatives in presence of inert solvent to produce 3,6-diphenylfuro[3,4-c]pyrrole-1,4-diones (furopyrroles); intermediates in process for preparation of diketopyrrolopyrroles; high yield and purity
05/03/2007US20070099991 Selective rxr ligands
05/03/2007US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
05/03/2007US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
05/03/2007US20070099971 (3R,5S,7as)-(3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol; does not involve microtubule stabilization; Alzheimer's
05/03/2007US20070099948 7-[4'S,5'R-4',6'-di-O-acetyl-2',3'-dideoxy-D-erythro-hex-2'-enopyranosyl]-oxymethyl camptothecin 20-(4-bromo)-n-butyrate; breast cancers, ovarian cancer, colon cancer, malignant melanoma, small cell lung cancer, thyroid cancers, lymphomas, leukemias, AIDS
05/03/2007US20070099945 Novel tricyclic spiroderivatives as modulators of chemokine receptor acitivity
05/03/2007US20070099940 Pth agonists
05/03/2007US20070099904 Pharmaceutical composition for the treatment of cns and other disorders